Biopharmaceutical company developing innovative therapies in the field of chronic inflammation
Location: United States, California, Los Altos
Total raised: $140.5M
Investors 4
| Date | Name | Website |
| - | Andera Par... | anderapart... |
| - | NFLS - Piv... | pivotalbio... |
| - | SymBiosis | symbiosis.... |
| 18.04.2022 | Life Scien... | lspvc.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.06.2023 | Series B | $7.5M | - |
| 26.04.2023 | Series B | $50M | Amplitude ... |
| 09.09.2021 | Series A | $83M | Andera Par... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 18.12.2023 | Pivotal bioVenture Partners closes $389M fund, bringing tota... | Pivotal bioVenture Partners has closed its second fund of $389 million, money that will go toward No... | fiercebiot... |
| 30.06.2023 | Recent Digital Health Hires & Board Appointments | Theralink Technologies, Inc. appoints Faith Zaslavsky as its new Chief Executive Officer. Ms. Zaslav... | hitconsult... |
| 28.06.2023 | Evommune Adds $7.5M to Series B Financing | Evommune, a Palo Alto, CA-based clinical-stage biotechnology company, raised additional $7.5M in Ser... | finsmes.co... |
| 26.04.2023 | Evommune Closes $50M Series B Financing | Evommune, a Palo Alto, CA-based clinical-stage biotechnology company, raised $50M in Series B fundin... | finsmes.co... |
| 09.09.2021 | Ex-Dermira founders pick up $83M for Evommune to advance pro... | Within a week of leaving Dermira after the dermatology medicines company sold to Eli Lilly for $1.1 ... | fiercebiot... |
| 09.09.2021 | Ex-Dermira founders pick up $83M for Evommune to advance pro... | Within a week of leaving Dermira after the dermatology medicines company sold to Eli Lilly for $1.1 ... | fiercebiot... |
| 09.09.2021 | Andera Partners leads US$ 83 million series A round in Evomm... | Evommune was founded in 2020 by industry veterans and former senior leaders at Dermira, a dermatolog... | anderapart... |
| 18.11.2020 | Evommune Snags $12M in Seed Funding | LOS ALTOS, CA, Evommune announced the successful completion of a $12.5 million seed financing. &g... | vcnewsdail... |
| 18.11.2020 | Evommune, Inc. Raises $12.5M in Seed Funding to Accelerate t... | LOS ALTOS, Calif., Nov. 18, 2020 /PRNewswire/ -- Evommune, Inc., an innovation engine in chronic i... | prnewswire... |
| - | Evommune | “Evommune | Discovering Treatments | Unlocking Possibilities” | fastfounde... |